Generation and characterization of anti-AA amyloid-specific monoclonal antibodies

Frontiers in Immunology

Volumn 2, Issue AUG, 2011, Pages

  Wall, Jonathan S ^a   Kennel, Stephen J ^a   Richey, Tina ^a   Allen, Amy ^a   Stuckey, Alan ^a   Weiss, Deborah T ^a   Macy, Sallie D ^a   Barbour, Robin ^b   Seubert, Peter ^b   Solomon, Alan ^a   Schenk, Dale ^b  

^a UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

^b ELAN PHARMACEUTICALS   (United States)

Author keywords

AA amyloidosis; Immunotherapy; Monoclonal antibodies; Radioimmunoimaging

Indexed keywords

EID: 84871540796     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2011.00032     Document Type: Article

References (28)

1. Alexandrescu, A. T. (2005). Amyloid accomplices and enforcers. Protein Sci. 14, 1-12.
2. Bard, F., Barbour, R., Cannon, C., Car-retto, R., Fox, M., Games, D., Guido, T., Hoenow, K., Hu, K., Johnson-Wood, K. Khan, K. Kholodenko, D., Lee, C., Lee, M., Motter, R. Nguyen, M., Reed, A., Schenk, D., Tang, P., Vasquez, N., Seubert, P., and Yed-nock, T. (2003). Epitope and iso-type specificities of antibodies to beta-amyloid peptide for protection against Alzheimer's disease-like neu-ropathology. Proc. Natl. Acad. Sci. U.S.A. 100,2023-2028.
3. Bard, F., Cannon, C., Barbour, R., Burke, R. L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Lieberburg, I., Motter, R., Nguyen, M., Soriano, F., Vasquez, N., Weiss, K., Welch, B., Seubert, P., Schenk, D., and Yed-nock, T. (2000). Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in amouse model of Alzheimer disease. Nat. Med. 6, 916-919.
4. Bohne, S., Sletten, K., Menard, R., Büh-ling, F., Vöckler, S., Wrenger, E., Roessner, A., and Röcken, C. (2004). Cleavage of AL amyloid proteins and AL amyloid deposits by cathepsins B, K, and L. J. Pathol. 203, 528-537.
5. Enqvist, S., Sletten, K., and Wester-mark, P. (2009). Fibril protein fragmentation pattern in systemic AL-amyloidosis. J. Pathol. 219,473-480.
6. Gillmore, J. D., Lovat, L. B., Persey, M. R., Pepys, M. B., and Hawkins, P. N. (2001). Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 358,24-29.
7. Hawkins, P. N., Aprile, C., Capri, G., Viganò, L., Munzone, E., Gianni, L., Pepys, M. B., and Merlini, G. (1998). Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis. Eur. J. Nucl. Med. 25,701-708.
8. Hawkins, P. N., Myers, M. J., Lavender, J. P., and Pepys, M. B. (1988). Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component. Lancet 1, 1413-1418.
9. Hazenberg, B. P., van Rijswijk, M. H., Piers, D. A., Lub-de Hooge, M. N., Vellenga, E., Haagsma, E. B., Hawkins, P. N., and Jager, P. L. (2006). Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis. Am. J. Med. 119, 355.e315-e324.
10. Hrncic, R., Wall, J., Wolfenbarger, D. A., Murphy, C. L., Schell, M., Weiss, D. T., and Solomon, A. (2000). Antibody-mediated resolution of light chain-associated amyloid deposits. Am. J. Pathol. 157, 1239-1246.
11. Kisilevsky, R., Tan, R., Subrahmanyan, L., and Snow, A. (1984). Are elevated serum amyloid A levels and amyloid-enhancing factor sufficient to induce inflammation-associated amyloid deposition? Appl. Pathol. 2, 308-315.
12. Monti, M., Amoresano, A., Giorgetti, S., Bellotti, V., and Pucci, P. (2005). Limited proteolysis in the investigation of beta2-microglobulin amyloido-genic and fibrillar states. Biochim. Biophys. Acta 1753,44-50.
13. O'Nuallain, B., Allen, A., Kennel, S. J., Weiss, D. T., Solomon, A., and Wall, J. S. (2007). Localization of aconfor-mational epitope common to non-native and fibrillar immunoglobu-lin light chains. Biochemistry 46, 1240-1247.
14. O'Nuallain, B., Murphy, C. L., Wolfenbarger, D. A., Kennel, S. J., Solomon, A., and Wall, J. S. (2005). "The amyloid-reactive monoclonal antibody 11-1F4 binds a cryptic epitope on fibrils and partially denatured immunoglobulin light chains and inhibits fibrillogenesis," in Amyloid and Amyloidosis: Proceedings of theXth International Symposium on Amyloidosis, eds G. Grateau, R. A. Kyle, and M. Skinner (Tours: CRC Press), 482-484.
15. Pras, M., Schubert, M., Zucker-Franklin, D., Rimon, A., and Franklin, E. C. (1968). The characterization of soluble amyloid prepared in water. J. Clin. Invest. 47, 924-933.
16. Röcken, C, Fandrich, M., Stix, B., Tan-nert, A., Hortschansky, P., Rein-heckel, T., Saftig, P., Kähne, T., Menard, R., Ancsin, J. B., and Büh-ling, F. (2006). Cathepsin protease activity modulates amyloid load in extracerebral amyloidosis. J. Pathol. 210,478-487.
17. Röcken, C., Menard, R., Bühling, F., Vöckler, S., Raynes, J., Stix, B., Krüger, S., Roessner, A., and Kähne, T. (2005). Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation. Ann. Rheum. Dis. 64,808-815.
18. Schroeter, S., Khan, K., Barbour, R., Doan, M., Chen, M., Guido, T., Gill, D., Basi, G., Schenk, D., Seubert, P., and Games, D. (2008). Immunother-apy reduces vascular amyloid-beta in PDAPP mice. J. Neurosci. 28, 6787-6793.
19. Senthilkumar, S., Chang, E., and Jayaku-mar, R. (2008). Diffusible amyloid oligomers trigger systemic amyloidosis in mice. Biochem. J. 415, 207-215.
20. Solomon, A., Weiss, D. T., Schell, M., Hrncic, R., Murphy, C. L., Wall, J., McGavin, M. D., Pan, H. J., Kabalka, G. W., and Paulus, M. J. (1999). Transgenic mouse model of AA amyloidosis. Am. J. Pathol. 154, 1267-1272.
21. Varga, J., Flinn, M. S., Shirahama, T., Rodgers, O. G., and Cohen, A. S. (1986). The induction of accelerated murine amyloid with human splenic extract. Probable role of amyloid enhancing factor. Virchows Arch. B Cell Pathol. In cl. Mol Pathol. 51, 177-185.
22. Wall, J. S., Kennel, S. J., Paulus, M. J., Gleason, S., Gregor, J., Baba, J., Schell, M., Richey, T., O'Nuallain, B., Donnell, R., Hawkins, P. N., Weiss, D. T., and Solomon, A. (2005). Quantitative high-resolution micro-radiographic imaging of amyloid deposits in a novel murine model of AA-amyloidosis. Amyloid 12, 149-156.
23. Wall, J. S., Kennel, S. J., Stuckey, A. C., Long, M. J., Townsend, D. W., Smith, G. T., Wells, K. J., Fu, Y., Stabin, M. G., Weiss, D. T., and Solomon, A. (2010). Radioimmunodetection of amyloid deposits in patients with AL amyloidosis. Blood 116,2241-2244.
24. Wall, J. S., Paulus, M. J., Gleason, S., Gre-gor, J., Solomon, A., and Kennel, S. J. (2006a). Micro-imaging of amyloid in mice. Meth. Enzymol. 412, 161-182.
25. Wall, J. S., Kennel, S. J., Paulus, M., Gre-gor, J., Richey, T., Avenell, J., Yap, J., Townsend, D., Weiss, D. T., and Solomon, A. (2006b). Radioimag-ing of light chain amyloid with a fibril-reactive monoclonal antibody. J. Nucl. Med. 47, 2016-2024.
26. Wall, J. S., Richey, T., Allen, A., Don-nell, R., Kennel, S. J., and Solomon, A. (2008). Quantitative tomography of early-onset spontaneous AA amyloidosis in interleukin 6 transgenic mice. Comp. Med. 58, 542-550.
27. Westermark, G. T., and Westermark, P. (2009). Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis. FEBS Lett. 583,2685-2690.
28. Yamada, T., Liepnieks, J. J., Kluve-Beckerman, B., and Benson, M. D. (1995). Cathepsin B generates the most common form of amyloid A (76 residues) as a degradation product from serum amyloid A. Scand. J. Immunol. 41, 94-97.